Bausch Health Companies Inc. has completed previously announced exchange offers involving its outstanding 4.875% and 11.00% Senior Secured Notes due 2028. In the transaction, the company and its indirect wholly owned subsidiary, 1261229 B.C. Ltd., exchanged these notes for up to $1.6 billion aggregate principal amount of new 10.00% Senior Secured Notes due 2032. The new notes, issued on December 26, 2025, are secured by a first priority lien on substantially all assets of the issuer and other guarantors, including a pledge of approximately 60% of the outstanding common shares of Bausch + Lomb Corporation. The exchange was executed under an indenture originally dated April 8, 2025, and supplemented on December 26, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000885590-25-000059), on December 29, 2025, and is solely responsible for the information contained therein.